Urmila Chandran
Papers
1
Total Citations
66
H-Index
1
About
Dr. Urmila Chandran is a leading epidemiologist and health outcomes researcher whose work focuses on cancer survivorship, recurrence patterns, and long-term outcomes in non-small cell lung cancer (NSCLC). Her landmark 2023 study on recurrence-free survival (RFS) in surgically resected NSCLC patients has garnered 66 citations, providing a critical summary estimate that fills a significant gap in the literature. This work systematically quantified post-surgical recurrence risks, offering clinicians and patients evidence-based benchmarks for prognosis and follow-up care. Dr. Chandran’s research is distinguished by its rigorous synthesis of real-world data, directly informing surveillance strategies and adjuvant therapy decisions. Her contributions have been instrumental in shifting the conversation from mere survival to recurrence-free survival as a key endpoint in NSCLC management. With a career dedicated to translating clinical questions into actionable evidence, Dr. Chandran continues to shape standards in thoracic oncology, empowering researchers and practitioners to improve long-term outcomes for lung cancer patients.
Research Focus
Key Achievements
Top Papers
- 1